MCMCB Pro
J2798

J2798Injection, risperidone, (perseris), 0.5 mg

HCPCSActiveBETOS O1E

J2798 is a HCPCS Level II code for injection, risperidone, (perseris), 0.5 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J2798 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
240 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
outpatient
240 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
DME supplier
240 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J2798

Long descriptor
Injection, risperidone, (perseris), 0.5 mg

The official wording. This is what the code means.

Short descriptor
Inj., perseris, 0.5 mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2019

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J2798

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2798 is not quite right, the correct code is very often within a few positions of it.

  • J2790Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
  • J2791Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu
  • J2792Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu
  • J2793Injection, rilonacept, 1 mg
  • J2794Injection, risperidone (risperdal consta), 0.5 mg
  • J2795Injection, ropivacaine hydrochloride, 1 mg
  • J2796Injection, romiplostim, 10 microgramsterminated
  • J2797Injection, rolapitant, 0.5 mg
  • J2799Injection, risperidone (uzedy), 1 mg
  • J2800Injection, methocarbamol, up to 10 ml
  • J2801Injection, risperidone (rykindo), 0.5 mg
  • J2802Injection, romiplostim, 1 microgram
  • J2804Injection, rifampin, 1 mg
  • J2805Injection, sincalide, 5 micrograms
  • J2806Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 microgramsterminated
  • J2810Injection, theophylline, per 40 mg

Questions about J2798

What is HCPCS code J2798?

J2798 is a HCPCS Level II code for injection, risperidone, (perseris), 0.5 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J2798?

The CMS HCPCS file marks J2798 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J2798 paid under the physician fee schedule?

J2798 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026